Titre : Mononeuropathies

Mononeuropathies : Questions médicales fréquentes

Termes MeSH sélectionnés :

Quantitative Structure-Activity Relationship
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Mononeuropathies : Questions médicales les plus fréquentes", "headline": "Mononeuropathies : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Mononeuropathies : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-01", "dateModified": "2025-03-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Mononeuropathies" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Neuropathies périphériques", "url": "https://questionsmedicales.fr/mesh/D010523", "about": { "@type": "MedicalCondition", "name": "Neuropathies périphériques", "code": { "@type": "MedicalCode", "code": "D010523", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.668.829" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mononeuropathie du nerf fémoral", "alternateName": "Femoral Neuropathy", "url": "https://questionsmedicales.fr/mesh/D020428", "about": { "@type": "MedicalCondition", "name": "Mononeuropathie du nerf fémoral", "code": { "@type": "MedicalCode", "code": "D020428", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.668.829.500.200" } } }, { "@type": "MedicalWebPage", "name": "Neuropathie du nerf médian", "alternateName": "Median Neuropathy", "url": "https://questionsmedicales.fr/mesh/D020423", "about": { "@type": "MedicalCondition", "name": "Neuropathie du nerf médian", "code": { "@type": "MedicalCode", "code": "D020423", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.668.829.500.500" } } }, { "@type": "MedicalWebPage", "name": "Neuropathies des nerfs péroniers", "alternateName": "Peroneal Neuropathies", "url": "https://questionsmedicales.fr/mesh/D020427", "about": { "@type": "MedicalCondition", "name": "Neuropathies des nerfs péroniers", "code": { "@type": "MedicalCode", "code": "D020427", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.668.829.500.600" } } }, { "@type": "MedicalWebPage", "name": "Neuropathie du nerf radial", "alternateName": "Radial Neuropathy", "url": "https://questionsmedicales.fr/mesh/D020425", "about": { "@type": "MedicalCondition", "name": "Neuropathie du nerf radial", "code": { "@type": "MedicalCode", "code": "D020425", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.668.829.500.650" } } }, { "@type": "MedicalWebPage", "name": "Neuropathie du nerf sciatique", "alternateName": "Sciatic Neuropathy", "url": "https://questionsmedicales.fr/mesh/D020426", "about": { "@type": "MedicalCondition", "name": "Neuropathie du nerf sciatique", "code": { "@type": "MedicalCode", "code": "D020426", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.668.829.500.675" } } }, { "@type": "MedicalWebPage", "name": "Neuropathie du nerf tibial", "alternateName": "Tibial Neuropathy", "url": "https://questionsmedicales.fr/mesh/D020429", "about": { "@type": "MedicalCondition", "name": "Neuropathie du nerf tibial", "code": { "@type": "MedicalCode", "code": "D020429", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.668.829.500.700" } } }, { "@type": "MedicalWebPage", "name": "Neuropathies ulnaires", "alternateName": "Ulnar Neuropathies", "url": "https://questionsmedicales.fr/mesh/D020424", "about": { "@type": "MedicalCondition", "name": "Neuropathies ulnaires", "code": { "@type": "MedicalCode", "code": "D020424", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.668.829.500.850" } } } ], "about": { "@type": "MedicalCondition", "name": "Mononeuropathies", "alternateName": "Mononeuropathies", "code": { "@type": "MedicalCode", "code": "D020422", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "John A Morren", "url": "https://questionsmedicales.fr/author/John%20A%20Morren", "affiliation": { "@type": "Organization", "name": "Neuromuscular Center, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio." } }, { "@type": "Person", "name": "Steven J Shook", "url": "https://questionsmedicales.fr/author/Steven%20J%20Shook", "affiliation": { "@type": "Organization", "name": "Neuromuscular Center, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio." } }, { "@type": "Person", "name": "S S Nikitin", "url": "https://questionsmedicales.fr/author/S%20S%20Nikitin", "affiliation": { "@type": "Organization", "name": "Research Centre for Medical Genetics, Moscow, Russia." } }, { "@type": "Person", "name": "Pitcha Chompoopong", "url": "https://questionsmedicales.fr/author/Pitcha%20Chompoopong", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Mayo Clinic, Rochester, MN, USA." } }, { "@type": "Person", "name": "James B Meiling", "url": "https://questionsmedicales.fr/author/James%20B%20Meiling", "affiliation": { "@type": "Organization", "name": "Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, Minnesota, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Design, Synthesis, Antibacterial Evaluation, Three-Dimensional Quantitative Structure-Activity Relationship, and Mechanism of Novel Quinazolinone Derivatives.", "datePublished": "2023-02-21", "url": "https://questionsmedicales.fr/article/36807581", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.jafc.2c07264" } }, { "@type": "ScholarlyArticle", "name": "Automated machine learning approach for developing a quantitative structure-activity relationship model for cardiac steroid inhibition of Na", "datePublished": "2023-06-24", "url": "https://questionsmedicales.fr/article/37354314", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s43440-023-00508-x" } }, { "@type": "ScholarlyArticle", "name": "Multivariate image analysis applied to quantitative structure-activity relationships and docking studies of recent hydroxyphenylpyruvate deoxygenase inhibitors.", "datePublished": "2023-04-18", "url": "https://questionsmedicales.fr/article/37021557", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jsfa.12608" } }, { "@type": "ScholarlyArticle", "name": "Artificial Intelligence-Based Quantitative Structure-Property Relationship Model for Predicting Human Intestinal Absorption of Compounds with Serotonergic Activity.", "datePublished": "2023-04-18", "url": "https://questionsmedicales.fr/article/37070956", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.molpharmaceut.2c01117" } }, { "@type": "ScholarlyArticle", "name": "Development of a quantitative structure-activity relationship model for predicting quantum yield of hydroxyl radical generation from organic compounds.", "datePublished": "2023-01-25", "url": "https://questionsmedicales.fr/article/36504232", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1039/d2em00396a" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système nerveux", "item": "https://questionsmedicales.fr/mesh/D009422" }, { "@type": "ListItem", "position": 3, "name": "Maladies neuromusculaires", "item": "https://questionsmedicales.fr/mesh/D009468" }, { "@type": "ListItem", "position": 4, "name": "Neuropathies périphériques", "item": "https://questionsmedicales.fr/mesh/D010523" }, { "@type": "ListItem", "position": 5, "name": "Mononeuropathies", "item": "https://questionsmedicales.fr/mesh/D020422" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Mononeuropathies - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Mononeuropathies", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Mononeuropathies", "description": "Comment diagnostiquer une mononeuropathie ?\nQuels examens sont nécessaires pour confirmer une mononeuropathie ?\nQuels signes cliniques indiquent une mononeuropathie ?\nLes tests sanguins sont-ils utiles pour le diagnostic ?\nQuelle est l'importance de l'historique médical ?", "url": "https://questionsmedicales.fr/mesh/D020422?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Mononeuropathies", "description": "Quels sont les symptômes courants d'une mononeuropathie ?\nComment se manifeste la douleur dans une mononeuropathie ?\nLes symptômes varient-ils selon le nerf touché ?\nPeut-on avoir des symptômes bilatéraux ?\nLes symptômes peuvent-ils s'aggraver avec le temps ?", "url": "https://questionsmedicales.fr/mesh/D020422?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Mononeuropathies", "description": "Comment prévenir les mononeuropathies ?\nLe contrôle du diabète aide-t-il à prévenir les mononeuropathies ?\nLes exercices physiques sont-ils bénéfiques ?\nFaut-il éviter certains sports ?\nLes pauses au travail sont-elles importantes ?", "url": "https://questionsmedicales.fr/mesh/D020422?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Mononeuropathies", "description": "Quels traitements sont disponibles pour les mononeuropathies ?\nLes médicaments peuvent-ils soulager la douleur ?\nLa physiothérapie est-elle efficace ?\nQuand la chirurgie est-elle nécessaire ?\nY a-t-il des traitements alternatifs ?", "url": "https://questionsmedicales.fr/mesh/D020422?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Mononeuropathies", "description": "Quelles complications peuvent survenir ?\nLa mononeuropathie peut-elle entraîner une incapacité ?\nLes infections sont-elles une complication possible ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D020422?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Mononeuropathies", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque de mononeuropathies ?\nLe travail répétitif est-il un facteur de risque ?\nLes maladies auto-immunes augmentent-elles le risque ?\nLe tabagisme est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D020422?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une mononeuropathie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique, l'électromyographie et des tests de conduction nerveuse." } }, { "@type": "Question", "name": "Quels examens sont nécessaires pour confirmer une mononeuropathie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des examens d'imagerie comme l'IRM peuvent être utilisés pour visualiser les nerfs." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une mononeuropathie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme la faiblesse musculaire, des engourdissements ou des douleurs localisées peuvent indiquer une mononeuropathie." } }, { "@type": "Question", "name": "Les tests sanguins sont-ils utiles pour le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent aider à identifier des causes sous-jacentes comme le diabète ou des carences." } }, { "@type": "Question", "name": "Quelle est l'importance de l'historique médical ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier des facteurs de risque et des antécédents de maladies nerveuses." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une mononeuropathie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur, engourdissement, picotements et faiblesse dans la zone affectée." } }, { "@type": "Question", "name": "Comment se manifeste la douleur dans une mononeuropathie ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "La douleur peut être aiguë, lancinante ou brûlante, souvent localisée le long du nerf affecté." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le nerf touché ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes dépendent du nerf affecté, par exemple, le nerf médian cause des symptômes dans la main." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes bilatéraux ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Généralement, les mononeuropathies sont unilatérales, mais des cas bilatéraux peuvent survenir." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils s'aggraver avec le temps ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sans traitement, les symptômes peuvent s'aggraver et entraîner des complications." } }, { "@type": "Question", "name": "Comment prévenir les mononeuropathies ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les positions prolongées et les mouvements répétitifs peut réduire le risque de mononeuropathies." } }, { "@type": "Question", "name": "Le contrôle du diabète aide-t-il à prévenir les mononeuropathies ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un bon contrôle glycémique peut réduire le risque de neuropathies diabétiques." } }, { "@type": "Question", "name": "Les exercices physiques sont-ils bénéfiques ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des exercices réguliers renforcent les muscles et améliorent la circulation nerveuse." } }, { "@type": "Question", "name": "Faut-il éviter certains sports ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des sports à fort impact peuvent augmenter le risque de blessures nerveuses, à éviter si possible." } }, { "@type": "Question", "name": "Les pauses au travail sont-elles importantes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, faire des pauses régulières aide à prévenir les tensions nerveuses dues à des positions statiques." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les mononeuropathies ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la physiothérapie, les médicaments anti-inflammatoires et parfois la chirurgie." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils soulager la douleur ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des analgésiques et des médicaments spécifiques comme les anticonvulsivants peuvent aider." } }, { "@type": "Question", "name": "La physiothérapie est-elle efficace ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la physiothérapie peut améliorer la force et la fonction nerveuse dans certains cas." } }, { "@type": "Question", "name": "Quand la chirurgie est-elle nécessaire ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est envisagée si les symptômes persistent malgré un traitement conservateur." } }, { "@type": "Question", "name": "Y a-t-il des traitements alternatifs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des approches comme l'acupuncture ou la thérapie par la chaleur peuvent être bénéfiques pour certains." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la perte de fonction, des douleurs chroniques et des déformations." } }, { "@type": "Question", "name": "La mononeuropathie peut-elle entraîner une incapacité ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, si non traitée, elle peut entraîner une incapacité fonctionnelle permanente." } }, { "@type": "Question", "name": "Les infections sont-elles une complication possible ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections peuvent survenir si la peau est lésée à cause de la perte de sensation." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent réduire la qualité de vie en limitant les activités quotidiennes et en causant de la douleur." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement précoce, d'autres non." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le diabète, l'alcoolisme, les maladies auto-immunes et les traumatismes." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de mononeuropathies ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge en raison de la dégradation nerveuse et des maladies associées." } }, { "@type": "Question", "name": "Le travail répétitif est-il un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les mouvements répétitifs peuvent entraîner des lésions nerveuses et des mononeuropathies." } }, { "@type": "Question", "name": "Les maladies auto-immunes augmentent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme le lupus ou la polyarthrite rhumatoïde peuvent prédisposer aux mononeuropathies." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut nuire à la circulation sanguine et augmenter le risque de neuropathies." } } ] } ] }

Sources (10000 au total)

Design, Synthesis, Antibacterial Evaluation, Three-Dimensional Quantitative Structure-Activity Relationship, and Mechanism of Novel Quinazolinone Derivatives.

Plant bacterial illnesses are common and cause dramatic damage to agricultural goods all over the world, yet there are few efficient bactericides to alleviate them at present. To discover novel antiba...

Automated machine learning approach for developing a quantitative structure-activity relationship model for cardiac steroid inhibition of Na

Quantitative structure-activity relationship (QSAR) modeling is a method of characterizing the relationship between chemical structures and biological activity. Automated machine learning enables comp... The chemical structures and inhibitory activities of 215 CS derivatives were obtained from the scientific literature. Predictive QSAR models were constructed using molecular descriptors, fingerprints,... The best predictive QSAR models were selected based on the LogLoss value. Using these models, the Matthews correlation coefficient, F1 score, and area under the curve of the test dataset were 0.6729, ... The automated machine learning-based QSAR method developed here should be applicable for the time-efficient construction of predictive models using only a small number of compounds....

Multivariate image analysis applied to quantitative structure-activity relationships and docking studies of recent hydroxyphenylpyruvate deoxygenase inhibitors.

Mesotrione is a triketone widely used as an inhibitor of the hydroxyphenylpyruvate deoxygenase (HPPD) enzyme. However, new agrochemicals should be developed continuously to tackle the problem of herbi... The MIA-QSAR models based on van der Waals radii (r... Multivariate image analysis descriptors corroborated by docking studies were capable of modeling the herbicidal activities of 68 triketones reliably. Due to the substituent effects at the triketone fr...

Artificial Intelligence-Based Quantitative Structure-Property Relationship Model for Predicting Human Intestinal Absorption of Compounds with Serotonergic Activity.

Oral medicines represent the largest pharmaceutical market area. To achieve a therapeutic effect, a drug must penetrate the intestinal walls, the main absorption site for orally delivered active pharm...

Development of a quantitative structure-activity relationship model for predicting quantum yield of hydroxyl radical generation from organic compounds.

Organic compounds are capable of generating hydroxyl radicals (˙OH) through their excited triplet states in natural water. It is of significance to reveal the underlying mechanism of the generation an...

In vitro and Quantitative and Structure Activity Relationship (QSAR) evaluation of the antifungal activity of terpenoid constituents of essential oils against Alternaria alternata and Fusarium oxysporum

Fungal genera Alternaria and Fusarium include human and plant pathogenic species. Several antifungals have been used for their control, but excessive use has contributed to resistance development in p... To evaluate in vitro and in silico the antifungal activities of terpenoids against Alternaria alternata and Fusarium oxysporum.... The minimum inhibitory concentration and minimum fungicidal concentration values of 27 constituents of essential oils used against Alternaria alternata and Fusarium oxysporum were evaluated in vitro. ... The evaluated compounds proved to be effective antifungals. Thymol was the most active with a minimum inhibitory concentration of 91.6 ± 28.8 μg/ml for A. alternata and F. oxysporum. Quantitative stru... Terpenoids exhibit relevant antifungal activities that should be incorporated into the study of medicinal chemistry. Inclusion of in silico assays in the in vitro evaluation is a valuable tool in the ...

Three-dimensional quantitative structural-activity relationship and molecular dynamics study of multivariate substituted 4-oxyquinazoline HDAC6 inhibitors.

3D-QSAR models were established by collecting 46 multivariate-substituted 4-oxyquinazoline HDAC6 inhibitors. The relationship of molecular structure and inhibitory activity was studied by comparative ...

Identification of Potent Small-Molecule PCSK9 Inhibitors Based on Quantitative Structure-Activity Relationship, Pharmacophore Modeling, and Molecular Docking Procedure.

The leading cause of atherosclerotic cardiovascular disease (ASCVD) is elevated low-density lipoprotein cholesterol (LDL-C). Proprotein convertase subtilisin/kexin type 9 (PCSK9) attaches to the domai...

An Empirical Quantitative Structure-Activity Relationship Equation Assists the Discovery of High-Affinity Phosphodiesterase 4D Inhibitors as Leads to PET Radioligands.

A positron emission tomography (PET) radioligand for imaging phosphodiesterase 4D (PDE4D) would benefit drug discovery and the investigation of neuropsychiatric disorders. The most promising radioliga...